{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P55317",
      "entity_text" : "FOXA1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0591" ],
      "Species" : [ "taxonomy:9986" ]
    }
  },
  "verbose_text" : "Altered FOXA1 levels contribute to endocrine resistant breast cancer, where it maintains ER-chromatin interactions, even in contexts in which cells are refractory to ER targeted drugs.",
  "reading_complete" : "2020-08-08T17:24:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T17:22:58Z",
  "trigger" : "levels",
  "evidence" : [ "FOXA1 levels" ],
  "pmc_id" : "6408623",
  "score" : 0
}